Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial

Urinary Potassium Excretion

Can It Predict the Onset of Hypertension?

Domenic A. Sica
Download PDF
https://doi.org/10.1161/HYPERTENSIONAHA.114.03874
Hypertension. 2014;64:693-694
Originally published July 28, 2014
Domenic A. Sica
From the Division of Nephrology, Virginia Commonwealth University Health System, Richmond.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Introduction
    • Disclosures
    • Footnotes
    • References
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

Introduction

See related article, pp 769–776

There are multiplicities of factors that have been proffered as physiological/dietary prompts for the new onset of hypertension. Such physiological factors generally center on changes in volume homeostasis, an excess of sympathetic nervous system activity, or either relative or absolute increases in various components of the renin–angiotensin–aldosterone system; however, population-based screening for changes in neurohumoral and volume-related factors associated with the new onset of hypertension is rarely done in clinical practice and for the most part, when attempted, has been sparingly predictive. Alternatively, at the individual patient level, the good clinician by virtue of an oftentimes thoughtfully applied algorithmic approach to treatment and simple neurohumoral testing can in a post hoc manner uncover the pathobiologic prompt to a newly developed hypertensive state.

Dietary factors actively involved in the genesis of hypertension have, however, received much more play because large population-based studies can be more readily initiated and outcomes tracked in a more longitudinally revealing manner. Of the many dietary factors invoked as causal in new-onset hypertension, sodium, potassium, magnesium, and calcium have been most commonly advanced as potentially etiologic and worthy of study. The details of many of these dietary studies have oftentimes been methodologically convoluted in that they have commonly relied on estimates of nutrient excretion or either spot or 12-hour overnight urine collections of these same nutrient cations and thus have been subject to critique based on the implied nature of the developed estimates.1 In that regard, in a prospective population-based cohort study, Kieneker et al2—Prevention of Renal and Vascular End-Stage Disease (PREVEND)—have chosen a more rigorous form of study in attempting to identify the relationship between urinary potassium excretion and the risk of developing hypertension by the use of 24-hour urine collections, the gold standard for assessing urinary nutrient/cation excretion and doing so in a time-wise fashion over a median follow-up of 7.6 years in a cohort of 5511 normotensive individuals aged 28 to 75 years.

The 24-hour urine excretion of potassium is, moreover, preferable for studies such as these in that it eliminates the interpretive considerations relative to the circadian variation in urinary excretion of potassium.3 Of note, several renal potassium transporters have been identified that have a circadian rhythmicity consistent with the observed daily fluctuations in urinary potassium excretion, making this phenomenon one of the several that need to be summed in the interpretation of urine potassium excretion measured in a longitudinally comparative fashion.4 In that regard, there is a well-established decrease in urinary potassium excretion at night, an observation that reverses in patients with chronic kidney disease.5

Assessing the time-wise intake of potassium by virtue of sequential 24-hour urine collections is not without other issues beyond the simple accuracy of the collection. To be able to reliably compare potassium content in urine collections obtained sequentially over time requires that potassium absorption be maintained as a constant percentage of intake; determinants of renal potassium handling remain comparable in their level of activity; cellular uptake of ingested potassium remains similar at the times of urine collection; and finally environmental conditions do not lead to varying and potentially excessive losses of potassium in sweat. Population-based studies such as the one performed by Kieneker et al2 are not designed to evaluate these influencing variables requiring that all 4 such variables be presumed to have been constant at the time of each urine collection. There is no certainty that this is the case until studied. For example, in other studies for as of yet not clearly established reasons, it has been shown that potassium excretion in black individuals, on both random diets and diets fixed for potassium intake, is commonly less than intake, making urine collections difficult to interpret if used in a singular fashion to approximate potassium intake.6

The question remains as to whether increasing the potassium intake of the population shifts the blood pressure distribution curve in favor of less incident hypertension as has been suggested for lowering the sodium intake in the general population. Be that as it may, there remains no single factor that a high potassium intake changes that can be seen as a standard for blood pressure reduction or preventing the transition from a normotensive to a hypertensive state. Factors considered in that regard include a greater natriuretic response to an increased potassium intake as well as decreased vascular responsiveness to vasopressor substances and increased sensitivity of the baroreceptor reflex. In addition, it has been shown that potassium supplementation converts otherwise normotensive salt-sensitive nondippers to dippers in the absence of an effect on daytime blood pressure.7 The issue of night-time blood pressure change was not intended for study by Kieneker et al,2 but one could speculate that in those with an implied higher potassium intake this might favorably influence overnight blood pressure. In so doing the impetus for daytime blood pressure increases, which might develop as a byproduct of higher nighttime readings or possibly a nocturnal nondipping state could conceivably be lessened.

Implicating intake/urinary excretion of potassium in the new onset of hypertension requires that other dietary nutrients be considered for their contribution to the developed state of hypertension. This same population in the PREVEND study has had the association of urinary magnesium excretion, as an indicator of intestinal magnesium absorption, also explored. In that regard, urinary magnesium excretion was found to be inversely associated with the risk of hypertension across the entire range of habitual dietary intake8; this association remained intact after adjustment for a wide range of variables, including urinary excretion of sodium, potassium, and calcium. The fact that this and the potassium excretion studies being reported were observational means that confounding variables of a dietary nature may have had some play in the findings. Moreover, one must wonder as to how the individual patient and his/her blood pressure responded to the dietary cross-talk occurring between potassium and magnesium intake.

In summary, the work of Kieneker et al2 provides support for what is a developing consensus that an increased potassium intake favorably influences both hypertension and the natural trajectory of blood pressure increase in the general population as well as the risk of incident stroke.9 Moreover, there seems to be no adverse effects from an increased potassium intake as related to lipid concentrations, catecholamine levels, or renal function as long as the patient so treated does not have renal disease in which case the risk of hyperkalemia becomes a relative deterrent to such an approach. Intervention trials including potassium consumption as high as 400 mmol per day from food for several weeks and 115 mmol per day for up to a year reported no adverse effects from increased potassium intake.10 This study, however, does not and cannot provide insight into what is an optimal potassium intake/urinary potassium excretion, and even the cut points for urinary potassium excretion offered have to be taken with a grain of salt as to their generalizability in that a homogeneous, nonethnically diverse population was being evaluated in the PREVEND study.

Disclosures

None

Footnotes

  • The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.

  • © 2014 American Heart Association, Inc.

References

  1. 1.↵
    1. Chien KL,
    2. Hsu HC,
    3. Chen PC,
    4. Su TC,
    5. Chang WT,
    6. Chen MF,
    7. Lee YT
    . Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan. J Hypertens. 2008;26:1750–1756.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Kieneker LM,
    2. Gansevoort RT,
    3. Mukamal KJ,
    4. de Boer RA,
    5. Navis G,
    6. Bakker SJL,
    7. Joosten MM
    . Urinary potassium excretion and risk of developing hypertension: the Prevention of Renal and Vascular End-Stage Disease Study. Hypertension. 2014; 64:769–776.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Buemi M,
    2. Campo S,
    3. Sturiale A,
    4. Aloisi C,
    5. Romeo A,
    6. Nostro L,
    7. Crascì E,
    8. Ruello A,
    9. Manfredini R,
    10. Floccari F,
    11. Cosentini V,
    12. Frisina N
    . Circadian rhythm of hydration in healthy subjects and uremic patients studied by bioelectrical impedance analysis. Nephron Physiol. 2007;106:p39–p44.
    OpenUrlPubMed
  4. 4.↵
    1. Gumz ML,
    2. Rabinowitz L
    . Role of circadian rhythms in potassium homeostasis. Semin Nephrol. 2013;33:229–236.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Agarwal R
    . Relationship between circadian blood pressure variation and circadian protein excretion in CKD. Am J Physiol Renal Physiol. 2007;293:F655–F659.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Turban S,
    2. Miller ER III.,
    3. Ange B,
    4. Appel LJ
    . Racial differences in urinary potassium excretion. J Am Soc Nephrol. 2008;19:1396–1402.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Wilson DK,
    2. Sica DA,
    3. Miller SB
    . Effects of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents. Hypertension. 1999;34:181–186.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Joosten MM,
    2. Gansevoort RT,
    3. Mukamal KJ,
    4. Kootstra-Ros JE,
    5. Feskens EJ,
    6. Geleijnse JM,
    7. Navis G,
    8. Bakker SJ
    ; PREVEND Study Group. Urinary magnesium excretion and risk of hypertension: the prevention of renal and vascular end-stage disease study. Hypertension. 2013;61:1161–1167.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Aburto NJ,
    2. Hanson S,
    3. Gutierrez H,
    4. Hooper L,
    5. Elliott P,
    6. Cappuccio FP
    . Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Rabelink TJ,
    2. Koomans HA,
    3. Hené RJ,
    4. Dorhout Mees EJ
    . Early and late adjustment to potassium loading in humans. Kidney Int. 1990;38:942–947.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
October 2014, Volume 64, Issue 4
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Introduction
    • Disclosures
    • Footnotes
    • References
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Urinary Potassium Excretion
    Domenic A. Sica
    Hypertension. 2014;64:693-694, originally published July 28, 2014
    https://doi.org/10.1161/HYPERTENSIONAHA.114.03874

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Urinary Potassium Excretion
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Urinary Potassium Excretion
    Domenic A. Sica
    Hypertension. 2014;64:693-694, originally published July 28, 2014
    https://doi.org/10.1161/HYPERTENSIONAHA.114.03874
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Cardiology
    • Etiology
      • Hypertension
        • Hypertension

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured